Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy

PURPOSE: The present study aimed at evaluating the efficacy of Raltitrexed, a specific thymidilate synthase inhibitor, in patients with advanced colorectal cancer (ACC) in relapse (>8 weeks) after a prior response or disease stabilization to first-line chemotherapy combination with lrinotecan+5-F...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsavaris, Nicolas, Kosmas, Christos, Vadiaka, Maria, Koufos, Christos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65542/
https://www.ncbi.nlm.nih.gov/pubmed/11860608
http://dx.doi.org/10.1186/1471-2407-2-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65542/
https://www.ncbi.nlm.nih.gov/pubmed/11860608
http://dx.doi.org/10.1186/1471-2407-2-2

Ejemplares similares